Pope ‘progressively improving,’ off I.V. tubes, moving about

By Philip Pullella ROME (Reuters) – Pope Francis’ overall condition is progressively improving and his post-surgical recovery is normal, allowing him to get out of bed, be detached from intravenous tubes and resume handling some Church work from his hospital armchair on Friday. Two statements from the Vatican, one in the early afternoon and the…

Read More

US Chamber of Commerce sues over government’s drug pricing power

By Jonathan Stempel (Reuters) -The U.S. Chamber of Commerce on Friday sued the federal government, challenging a new law that for the first time gives Medicare the power to negotiate drug prices with pharmaceutical companies. In a complaint filed in federal court in Dayton, Ohio, the chamber said the pricing program violated drugmakers’ due process…

Read More

Biden admin near deal to preserve preventive care coverage, for now

By Brendan Pierson (Reuters) – A mandate that U.S. health insurers cover preventive care like cancer screenings and HIV-preventing medication at no extra cost to patients could remain in place while the Biden administration appeals a court order striking it down, following a tentative agreement announced on Friday. The agreement between the administration and conservative…

Read More

US judge rejects 3M effort to resolve earplug lawsuits in bankruptcy

By Dietrich Knauth NEW YORK (Reuters) -A U.S. judge on Friday dismissed the bankruptcy of 3M subsidiary Aearo Technologies, rejecting an effort to resolve nearly 260,000 lawsuits alleging that 3M military earplugs caused hearing loss for veterans and U.S. service members. U.S. Bankruptcy Judge Jeffrey Graham in Indianapolis ruled that Aearo, as a well-supported subsidiary…

Read More

Exclusive-US seeks new suppliers of highly used cancer drug methotrexate in short supply

By Julie Steenhuysen and Michael Erman (Reuters) – The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to shore up two other scarce chemotherapy medicines. An FDA spokesperson told Reuters the agency is…

Read More